Abbott Laboratories (ABT) — Stock Price, Chart & Analysis
Abbott Laboratories (ABT) is a Healthcare stock currently trading at $100, up 0.00% on the day. It carries a market capitalization of $179.42B and a trailing P/E ratio of 33.34. Over the past 52 weeks, ABT has traded between $81.97 and $136.88. Abbott Laboratories pays a dividend yielding 2.5%. View the live ABT chart, technical opinion, analyst ratings, fundamentals and latest news below.
Abbott Laboratories (ABT) key data
| Price | $100 |
| Change (today) | +0.00% |
| Previous close | $100 |
| Market cap | $179.42B |
| P/E ratio (TTM) | 33.34 |
| EPS (TTM) | $3.11 |
| Dividend yield | 2.5% |
| 52-week high | $136.88 |
| 52-week low | $81.97 |
| Beta | 0.59 |
| Avg. volume | 10.23M |
| Sector | Healthcare |
| Industry | Medical Devices |
Frequently asked questions about Abbott Laboratories (ABT)
How much does one share of Abbott Laboratories cost?
As of the latest update, one share of Abbott Laboratories (ABT) trades at $100 (+0.00% today).
What is Abbott Laboratories's market cap?
Abbott Laboratories has a market capitalization of approximately $179.42B.
What is Abbott Laboratories's P/E ratio?
Abbott Laboratories has a trailing price-to-earnings (P/E) ratio of 33.34.
What is Abbott Laboratories's earnings per share (EPS)?
Abbott Laboratories's trailing twelve-month EPS is $3.11.
Does Abbott Laboratories pay a dividend?
Yes — Abbott Laboratories pays a dividend with a yield of 2.5% ($2.52 per share annually).
What is Abbott Laboratories's 52-week trading range?
Over the past year, ABT has traded between $81.97 and $136.88.
What is the analyst price target for Abbott Laboratories?
The mean analyst price target for Abbott Laboratories is $120.26. This is informational only and not investment advice.
Latest Abbott Laboratories (ABT) news
- Abbott And Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic HealthNews · Sep 23, 2026
- Capitalize on the Therapeutic Drug Monitoring Shift: Benchmark Roche, Abbott, Siemens Healthineers, Thermo Fisher and Bio-Rad to Accelerate Revenue and Defend Market ShareNews · Sep 23, 2026
- Abbott Laboratories vs. Intuitive Surgical: Recent Quarterly Revenue Trends Reveal a Classic Investing TruthNews · Sep 21, 2026
- SMARTIES™ Vietnam Announces 2026 Shortlist, Celebrating 187 Standout EntriesNews · Sep 21, 2026
- Global Wearable Biosensors Market Trends, Strategies and Forecast to 2036 Featuring Abbott Labs, Dexcom, Medtronic, Roche, Apple, Samsung Electronics Co., Garmin and Other Key PlayersNews · Sep 21, 2026
- Why Wall Street Is Becoming Even More Bullish About This Dividend KingNews · Sep 18, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live ABT dashboard…